Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy

Mette T Mouritzen, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Anders W M Nielsen, Anna Livbjerg, Jacob W Larsen, Halla Skuladottir, Charlotte Kristiansen, Kim Wedervang, Tine Schytte, Karin H Hansen, Anne-Cathrine Østby, Malene S Frank, Jakob Lauritsen, Jens B Sørensen, Seppo W Langer, Gitte F Persson, Jon L Andersen, Johanna M C FraryLars B Drivsholm, Charles Vesteghem, Heidi S Christensen, Birgitte Bjørnhart, Mette Pøhl

Fingeraftryk

Dyk ned i forskningsemnerne om 'Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology